ANDREA FAGIOLINI

Professor of Psychiatry

Università degli Studi di Siena

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

ORCID

Google Scholar

Articles (19)

Unraveling the Boundaries, Overlaps, and Connections between Schizophrenia and Obsessive–Compulsive Disorder (OCD)

Article Link

Year:

2024

Efficacy of topiramate in treating obsessive compulsive disorder: A systematic review and meta-analysis

Article Link

Year:

2024

Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice

Article Link

Year:

2024

Finding the Right Setting for the Right Treatment During the Acute Treatment of Individuals with Schizophrenia: A Narrative Review and Clinical Practice Guideline

Article Link

Year:

2024

Is intravenous valproate more efficacious than oral valproate for inpatients with bipolar I disorder with a manic or depressive episode and concomitant symptoms of opposite polarity?

Article Link

Year:

2024

On the Road to Individualizing Pharmacotherapy for Adolescents and Adults with Schizophrenia – Results from an Expert Consensus Following the Delphi Method

Article Link

Year:

2024

About the paper ‘Apathy associated with antidepressants: a systematic review’

Article Link

Year:

2024

Clinical benefits and bioequivalence of vortioxetine oral drop solution versus oral tablets

Article Link

Year:

2024

The relationship between obsessive–compulsive symptoms and real-life functioning in schizophrenia: New insights from the multicenter study of the Italian Network for Research on Psychoses

Article Link

Year:

2024

Vortioxetine in patients with major depressive disorder and high levels of anxiety symptoms: An updated analysis of efficacy and tolerability

Article Link

Year:

2023

Clinical benefits of vortioxetine 20 mg/day in patients with major depressive disorder

Article Link

Year:

2023

Treating major depressive disorder with mixed features

Article Link

Year:

2023

Vortioxetine 20 mg/day in patients with major depressive disorder: updated analysis of efficacy, safety, and optimal timing of dose adjustment

Article Link

Year:

2023

Heterozygosity for neuronal ceroid lipofuscinosis predisposes to bipolar disorder

Article Link

Year:

2023

Circadian neuromarkers of mood disorders

Article Link

Year:

2022

Emotional blunting in patients with depression. Part I: clinical characteristics

Article Link

Year:

2022

Emotional blunting in patients with depression. Part II: relationship with functioning, well-being, and quality of life

Article Link

Year:

2022

Emotional blunting in patients with depression. Part III: relationship with psychological trauma

Article Link

Year:

2022

Emotional blunting in patients with depression. Part IV: differences between patient and physician perceptions

Article Link

Year:

2022

Collaborators (4)

Giovanni Barillà

University of Siena

ITALY

Simone Furini

University of Bologna

ITALY

Matteo Cattolico

University of Siena

ITALY

Pietro Carmellini

University of Siena

ITALY

ANDREA FAGIOLINI

Research Interests

Explore related searches

Contact this professor

Articles (19)

Unraveling the Boundaries, Overlaps, and Connections between Schizophrenia and Obsessive–Compulsive Disorder (OCD)

Efficacy of topiramate in treating obsessive compulsive disorder: A systematic review and meta-analysis

Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice

Finding the Right Setting for the Right Treatment During the Acute Treatment of Individuals with Schizophrenia: A Narrative Review and Clinical Practice Guideline

Is intravenous valproate more efficacious than oral valproate for inpatients with bipolar I disorder with a manic or depressive episode and concomitant symptoms of opposite polarity?

On the Road to Individualizing Pharmacotherapy for Adolescents and Adults with Schizophrenia – Results from an Expert Consensus Following the Delphi Method

About the paper ‘Apathy associated with antidepressants: a systematic review’

Clinical benefits and bioequivalence of vortioxetine oral drop solution versus oral tablets

The relationship between obsessive–compulsive symptoms and real-life functioning in schizophrenia: New insights from the multicenter study of the Italian Network for Research on Psychoses

Vortioxetine in patients with major depressive disorder and high levels of anxiety symptoms: An updated analysis of efficacy and tolerability

Clinical benefits of vortioxetine 20 mg/day in patients with major depressive disorder

Treating major depressive disorder with mixed features

Vortioxetine 20 mg/day in patients with major depressive disorder: updated analysis of efficacy, safety, and optimal timing of dose adjustment

Heterozygosity for neuronal ceroid lipofuscinosis predisposes to bipolar disorder

Circadian neuromarkers of mood disorders

Emotional blunting in patients with depression. Part I: clinical characteristics

Emotional blunting in patients with depression. Part II: relationship with functioning, well-being, and quality of life

Emotional blunting in patients with depression. Part III: relationship with psychological trauma

Emotional blunting in patients with depression. Part IV: differences between patient and physician perceptions

Collaborators (4)

Giovanni Barillà

Simone Furini

Matteo Cattolico

Pietro Carmellini

How do I reach out?

Meet Kite AI